In a news release today, the FDA announced its approval of a marijuana-derived drug called Epidiolex for the treatment of seizures in a subset of patients suffering from severe epilepsy. Epidiolex contains CBD, a cannabis chemical compound skyrocketing in popularity and driving what is estimated to have doubled into a $200 million market in 2018.
CBD is the common abbreviation for cannabidiol, a chemical derived from cannabis. In contrast to THC, the far more popular cannabinoid CBD does not produce strong psychoactive effects when consumed. The chemical’s use in seizure prevention is well-documented in reputable research, and now, after conducting its own trials, the FDA is on board.
As the FDA itself notes, “this is the first FDA-approved drug that contains a purified drug substance derived from marijuana.” Epidiolex, produced by GW Research Ltd., is now approved to treat the conditions known as Lennox-Gastaut syndrome and Dravet syndrome.
The FDA news signals that the DEA will [...]read more
Apple's iOS 12 public beta is now available to everyone with a willingness to test the new software on their iPhone and iPad.
Its big highlight is that it'll make your older devices faster, according to Apple. The iPhone 6 Plus, for example, is 40% faster at launching apps, 70% faster at launching the camera app, and 50% faster at displaying the keyboard.
There are also a bunch of front-facing features, including Grouped Notifications, Group FaceTime, and ARKit 2 for multiplayer gaming – so much room for group activities.
iOS 12 first impressions: 10 specific ways iOS 12 can change your daily life
Memoji, the personalized Animoji that are supposed to look like you or 'the real you', according to Apple, are also part of today's iOS 12 public beta. They can even be used in FaceTime and Group FaceTime.
There's a new Measure app and refreshes to Apple News, Stocks, Voice Memos and even CarPlay. iPads get updated to iPhone X-like gesture controls, likely making room for new 2018 iPad Pro models.